At the news
? NEUTRALIMPACT 2/10 8-K filed Nov 3, 2026 at 16:42 ET
Procter & Gamble closed an underwritten public offering of EUR 3.25 billion in aggregate principal amount of senior notes across four tranches: EUR 750 million of 3.750% notes due 2030, EUR 1.0 billion of 4.100% notes due 2034, EUR 750 million of 4.250% notes due 2038, and EUR 750 million of 4.625% notes due 2046. The proceeds will be used for general corporate purposes. This is a routine debt capital markets transaction for a large investment-grade issuer and has no material impact on equity holders.
- Closed underwritten public offering of EUR 3.25 billion aggregate principal amount of senior notes on November 3, 2026.
- Four tranches: EUR 750M 3.750% notes due 2030, EUR 1.0B 4.100% notes due 2034, EUR 750M 4.250% notes due 2038, EUR 750M 4.625% notes due 2046.
- Offered under existing shelf registration statement on Form S-3 (File No. 333-299472).
- Pricing agreements were dated October 27, 2026, with the closing on November 3, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access